# Stephen P. Hunger

Source: https://onco.cc/people/stephen-hunger/  
OnCo record `stephen-hunger` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Chaired the COG leukaemia committee through the era that pushed childhood ALL cure rates above 90%.

## Summary

Stephen Hunger chaired the Children's Oncology Group acute lymphoblastic leukaemia committee from 2008 to 2016 and led the analyses documenting improved survival across successive trials, the Ph-like ALL discovery work with Charles Mullighan, and the trials that added imatinib to chemotherapy for Philadelphia-positive ALL. He co-authored the NEJM review of childhood ALL and leads oncology at CHOP.

## Fields

- Kind: Person
- Last checked: 2026-09-10
- Tags: paediatric; all; cooperative-group
- Role: Chief, Division of Oncology, Children's Hospital of Philadelphia; Jeffrey E. Perelman Distinguished Chair in Pediatrics
- Specialisms: Paediatric acute lymphoblastic leukaemia; Cooperative-group trials; Leukaemia genomics; Risk stratification

## Sources

- Wikipedia: https://en.wikipedia.org/wiki/Stephen_P._Hunger
- PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Hunger%20SP%5BAuthor%5D%20acute%20lymphoblastic%20leukemia%20children

## Connected records

- cancers: [Acute lymphoblastic leukaemia](https://onco.cc/cancers/all-leukemia/)
- drugs: [Blinatumomab](https://onco.cc/drugs/blinatumomab/), [Imatinib](https://onco.cc/drugs/imatinib/)
- institutions: [Children's Hospital of Philadelphia](https://onco.cc/institutions/chop/)
- trials: [COG AALL1731](https://onco.cc/trials/aall1731/)
- key papers: [Children's Oncology Group AALL1731: blinatumomab added to chemotherapy for children with standard-risk B-cell ALL](https://onco.cc/key-papers/paper-aall1731-blinatumomab-children-nejm-2025/)

---
JSON: https://onco.cc/api/v1/entities/stephen-hunger.json